According to study, “World Membrane Oxygenator Market
Research Report 2024(covering USA, EU, China, South East Asia, Japan and etc)”
the key companies operating in the world membrane oxygenator market areMedosMedizintechnik
AG,Eurosets S.R.L., WEGO, Sorin Group,Kewei (Microport), Xijian Medical,Abbott
Pvt Ltd., Getinge Group, Shanghai Microport Orthopedics, Alung Technologies
Inc., Medtronic Plc,Nipro Medical Corp., Terumo Cardiovascular Systems,Xenios
AG, Origen Biomedical Inc., Fresenius Medical Care AG & Co. KGaA, Siemens
AG, Agilent Technologies, MAQUET Holding B.V. & Co. KG, BraileBiomedica, Livanova
Plc, Chalice Medical.The key players are focusing on product launches,
agreements, approvals, partnerships, expansions, and acquisitions to increase
their product portfolios & customer bases, augment their sales channels,
and proliferation their global presence.
Membrane oxygenator is a device or machine used to add
oxygen and remove carbon dioxide from the blood. It is used in two principal
modes: to oxygenate blood in longer term life support and to imitate the
function of the lungs in cardiopulmonary bypa (CPB). It is also termed as life
support machine and Extracorporeal membrane oxygenation machine (ECMO). It is
used in the treatment of several heart & lung disease. Its main function is
to provide enough oxygen to the body when heart & lung are not functioning
properly. Some of the risk included infections, bleeding, and technical
failures.
Based on type, membrane oxygenator market is segmented into hollow
fiber membrane oxygenat or and flat sheet membrane oxygenator. Based on
component, market is segmented into pumps (centrifugal pumps & roller
pumps), controllers, oxygenators, accessories and cannula. The pumps segment is
expected to be the fastest-growing owing to increase in incidences of asthma. Based
on modality, market is segmented into Veno-Venous (VV), Veno-Arterial (VA) and
Arterio-Venous (AV). Modalities are used to provide hemodynamic support &
to help gaseous exchange in patients with cardiac or respiratory failure. The VA
segment is anticipated to hold a major share in the market as a result of its
widespread use in the treatment of cardiovascular collapse. Based on
application, market is segmented into cardiac, respiratory and Extracorporeal
Cardiopulmonary Resuscitation (ECPR). Cardiac application includes pediatric,
neonates and adults. In addition, based on end-use, market is segmented into
pediatric, neonates and adults.
The membrane oxygenator market is driven by rise in
incidence in Chronic Obtrusive Pulmonary Diseases (COPD), followed by increase
in incidences of cardiac disorders, rise in adoption of ECMO machines, increase
in investment in research & development (R&D) of new medical devices, favorable
reimbursement scenario, growth in awareness about health disorder, rise in
tobacco consumption and growth in technological advancements. However, presence
of alternative techniques, risks associated with ECMO treatment and high cost
of ECMO procedures may impact the market. Moreover, increase in survival rates
with ECMO is a key opportunity for market.
Based on geography, USA country holds major share, followed
by EU, inmembrane oxygenator market owing to increase in technological
acceptance, rise in availability of state-of-the-art health facilities and high
investment in research & development. India and China countries are
expected to witness higher growth rate due to increase in prevalence of
respiratory illnesses, and growth in development of health infrastructure over
the forecast period. It is projected that market will be reached at rapid pace
on account of new product development & technological advancements over the
forecast period.
For more information on the research
report, refer to below link:
Related reports
Contact Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
